Literature DB >> 12679875

Polymorphism of the codon 129 of the prion protein (PrP) gene and neuropathology of cerebral ageing.

Claudine Berr1, Nicole Helbecque, Véronique Sazdovitch, Michel Mohr, Carole Amant, Philippe Amouyel, Annick Alpérovitch, Jean-Jacques Hauw.   

Abstract

We studied whether codon 129 polymorphism of the PrP gene modulates the presence of tau- and Abeta-associated lesions among 188 patients over 70 years of age without evidence of dementia. Val allele carriers, either heterozygotes or homozygotes, were more frequently affected by Abeta-associated lesions than non Val allele carriers, whereas there were no differences for tau-positive neurones. Val allele carriers also had more focal and diffuse Abeta deposits. This association was most significant in the highest Braak's stages for neurofibrillary tangles (>/=III). In this group, cases with at least one Val allele had nearly twice as many Abeta-associated lesions. The most affected areas were the entorhinal cortex, TF-TH and the superior temporal cortex, where odds ratios for focal Abeta deposits ranged from 3.5 to 4.6.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12679875     DOI: 10.1007/s00401-003-0700-7

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  9 in total

1.  Comment on "The codon 129 polymorphism of the prion protein gene influences earlier cognitive performance in Down syndrome subjects"--by Del Bo et al. in J Neurol (2003) 250:688-692.

Authors:  Alisdair McNeill
Journal:  J Neurol       Date:  2004-07       Impact factor: 4.849

2.  Analysis of the polymorphic prion protein gene codon 129 in idiopathic Parkinson's disease.

Authors:  G Gossrau; B Herting; S Möckel; A Kempe; R Koch; H Reichmann; J B Lampe
Journal:  J Neural Transm (Vienna)       Date:  2005-07-06       Impact factor: 3.575

3.  Prnp gene and cerebellum volume in patients with refractory mesial temporal lobe epilepsy.

Authors:  Michelle N Valadão; Erica R Coimbra; Michele C Landemberger; Tonicarlo R Velasco; Vera C Terra; Lauro Wichert-Ana; Veriano Alexandre; David Araújo; Ricardo Guarnieri; Vilma R Martins; Antônio Carlos Santos; Américo C Sakamoto; Roger Walz
Journal:  Neurol Sci       Date:  2013-10-05       Impact factor: 3.307

4.  The prion protein M129V polymorphism: longevity and cognitive impairment among Polish centenarians.

Authors:  Ewa Golanska; Monika Sieruta; Elizabeth Corder; Sylwia M Gresner; Anna Pfeffer; Malgorzata Chodakowska-Zebrowska; Tomasz M Sobow; Izabela Klich; Malgorzata Mossakowska; Aleksandra Szybinska; Maria Barcikowska; Pawel P Liberski
Journal:  Prion       Date:  2013-02-13       Impact factor: 3.931

Review 5.  Insoluble cellular prion protein and its association with prion and Alzheimer diseases.

Authors:  Wen-Quan Zou; Xiaochen Zhou; Jue Yuan; Xiangzhu Xiao
Journal:  Prion       Date:  2011-07-01       Impact factor: 3.931

6.  Amyloid-beta42 interacts mainly with insoluble prion protein in the Alzheimer brain.

Authors:  Wen-Quan Zou; Xiangzhu Xiao; Jue Yuan; Gianfranco Puoti; Hisashi Fujioka; Xinglong Wang; Sandy Richardson; Xiaochen Zhou; Roger Zou; Shihao Li; Xiongwei Zhu; Patrick L McGeer; John McGeehan; Geoff Kneale; Diego E Rincon-Limas; Pedro Fernandez-Funez; Hyoung-gon Lee; Mark A Smith; Robert B Petersen; Jian-Ping Guo
Journal:  J Biol Chem       Date:  2011-03-10       Impact factor: 5.157

7.  Intragenic modifiers of hereditary spastic paraplegia due to spastin gene mutations.

Authors:  Ingrid K Svenson; Mark T Kloos; P Craig Gaskell; Martha A Nance; James Y Garbern; Shin-ichi Hisanaga; Margaret A Pericak-Vance; Allison E Ashley-Koch; Douglas A Marchuk
Journal:  Neurogenetics       Date:  2004-07-10       Impact factor: 2.660

8.  Prion Protein Modulates Monoaminergic Systems and Depressive-like Behavior in Mice.

Authors:  Danielle Beckman; Luis E Santos; Tatiana A Americo; Jose H Ledo; Fernando G de Mello; Rafael Linden
Journal:  J Biol Chem       Date:  2015-07-07       Impact factor: 5.157

9.  Human tau protein forms complex with PrP and some GSS- and fCJD-related PrP mutants possess stronger binding activities with tau in vitro.

Authors:  Xiao-Fan Wang; Chen-Fang Dong; Jin Zhang; Yan-Zhen Wan; Feng Li; Yin-Xia Huang; Lu Han; Bing Shan; Chen Gao; Jun Han; Xiao-Ping Dong
Journal:  Mol Cell Biochem       Date:  2007-11-25       Impact factor: 3.396

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.